FDA Approval Summary: Sonidegib-Response

Clin Cancer Res. 2017 Oct 1;23(19):5994. doi: 10.1158/1078-0432.CCR-17-2135.

Authors

Stacy S Shord¹, Denise Casey², Hong Zhao², Suzanne Demko², Patricia Keegan², Richard Pazdur²

Affiliations

¹ Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. stacy.shord@fda.hhs.gov.
² Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

PMID: 28972086
DOI: 10.1158/1078-0432.CCR-17-2135

No abstract available

Publication types

Letter
Comment

MeSH terms

Biphenyl Compounds
Carcinoma, Basal Cell*
Humans
Pyridines
Skin Neoplasms*

Substances

Biphenyl Compounds
Pyridines
sonidegib